SCHEMBL6984749

SCHEMBL6984749

O=S(=O)(Cc1ccccc1)Nc1ccc2c(c1)NCCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 1/20 0.50
CYP19A1 P11511 1/20 0.49
AR P10275 1/20 0.48
KMT2A Q03164 1/20 0.48
BRD4 O60885 2/20 0.46
PGR P06401 1/20 0.46
FSHR P23945 1/20 0.44
HPGD P15428 2/20 0.44
HDAC1 Q13547 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN5 P54829 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6984534 0.90 MLNR (0.53) MLNRCYP19A1ARKMT2ABRD4
SCHEMBL6979531 0.81 HTR6 (0.61) KMT2ABRD4HPGDKDM4EALDH1A1
SCHEMBL12375664 0.78 GFER (0.47) KMT2AHPGDHDAC1KDM4EALDH1A1
SCHEMBL29817718 0.78 LMNA (0.44) MLNRCYP19A1ARBRD4HDAC1
SCHEMBL28156613 0.78 LMNA (0.44) MLNRCYP19A1ARBRD4HDAC1
SCHEMBL6984536 0.73 GLO1 (0.48) KMT2APGRHPGDKDM4EALDH1A1
SCHEMBL28798035 0.71 NLRP3 (0.65) MLNRKMT2AFSHRKDM4E
SCHEMBL6984820 0.70 HTR6 (0.61) KMT2ABRD4HPGDKDM4EALDH1A1
SCHEMBL11973901 0.70 TRPV1 (0.55) KMT2AKDM4EALDH1A1
SCHEMBL12359701 0.69 SMN1; SMN2 (0.52) KMT2AHPGDHDAC1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed